| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer
|
Chang, H.J.
|
|
|
23 |
4 |
p. 911-918
|
artikel
|
| 2 |
Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time
|
Cluze, C.
|
|
|
23 |
4 |
p. 882-890
|
artikel
|
| 3 |
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study
|
Jouary, T.
|
|
|
23 |
4 |
p. 1074-1080
|
artikel
|
| 4 |
A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma
|
Starling, N.
|
|
|
23 |
4 |
p. 942-947
|
artikel
|
| 5 |
A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy
|
Stebbing, J.
|
|
|
23 |
4 |
p. 860-866
|
artikel
|
| 6 |
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
|
Campanati, A.
|
|
|
23 |
4 |
p. 1081-1082
|
artikel
|
| 7 |
A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
|
Chia, W.K.
|
|
|
23 |
4 |
p. 997-1005
|
artikel
|
| 8 |
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
|
Tolcher, A.W.
|
|
|
23 |
4 |
p. 968-973
|
artikel
|
| 9 |
Autoimmune disease and subsequent digestive tract cancer by histology
|
Hemminki, K.
|
|
|
23 |
4 |
p. 927-933
|
artikel
|
| 10 |
Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose–response meta-analysis of prospective studies
|
Aune, D.
|
|
|
23 |
4 |
p. 843-852
|
artikel
|
| 11 |
Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II study
|
Kato, T.
|
|
|
23 |
4 |
p. 933-941
|
artikel
|
| 12 |
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab†
|
Malka, D.
|
|
|
23 |
4 |
p. 919-927
|
artikel
|
| 13 |
Diagnosis of invasive fungal infections in hematology and oncology—guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)
|
Ruhnke, M.
|
|
|
23 |
4 |
p. 823-833
|
artikel
|
| 14 |
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
|
Bianchi, M.
|
|
|
23 |
4 |
p. 973-980
|
artikel
|
| 15 |
Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates?
|
Allawi, Z.
|
|
|
23 |
4 |
p. 866-869
|
artikel
|
| 16 |
Editorial board
|
|
|
|
23 |
4 |
p. ii-iii
|
artikel
|
| 17 |
Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trial
|
Arias de la Vega, F.
|
|
|
23 |
4 |
p. 1005-1009
|
artikel
|
| 18 |
European cancer mortality predictions for the year 2012
|
Malvezzi, M.
|
|
|
23 |
4 |
p. 1044-1052
|
artikel
|
| 19 |
Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas
|
Gronchi, A.
|
|
|
23 |
4 |
p. 1067-1073
|
artikel
|
| 20 |
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers
|
Tan, E.-H.
|
|
|
23 |
4 |
p. 1010-1016
|
artikel
|
| 21 |
Identifying factors that impact survival among women with inflammatory breast cancer
|
Dawood, S.
|
|
|
23 |
4 |
p. 870-875
|
artikel
|
| 22 |
Imaging bone metastases in breast cancer: evidence on comparative test accuracy
|
Houssami, N.
|
|
|
23 |
4 |
p. 834-843
|
artikel
|
| 23 |
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients
|
Brunnberg, U.
|
|
|
23 |
4 |
p. 990-996
|
artikel
|
| 24 |
Intensified chemotherapy with stem-cell rescue in germ-cell tumors
|
Simonelli, M.
|
|
|
23 |
4 |
p. 815-822
|
artikel
|
| 25 |
Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case–control study in Japan
|
Chihara, D.
|
|
|
23 |
4 |
p. 1061-1066
|
artikel
|
| 26 |
Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
|
Yerushalmi, R.
|
|
|
23 |
4 |
p. 876-881
|
artikel
|
| 27 |
Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study
|
Nam, J.-H.
|
|
|
23 |
4 |
p. 903-911
|
artikel
|
| 28 |
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
|
Hitt, R.
|
|
|
23 |
4 |
p. 1016-1022
|
artikel
|
| 29 |
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors
|
Chew, H.K.
|
|
|
23 |
4 |
p. 1023-1029
|
artikel
|
| 30 |
Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors
|
Galsky, M.D.
|
|
|
23 |
4 |
p. 1037-1044
|
artikel
|
| 31 |
Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers
|
Kim, S.J.
|
|
|
23 |
4 |
p. 891-897
|
artikel
|
| 32 |
Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study
|
Macfarlane, T.V.
|
|
|
23 |
4 |
p. 1053-1060
|
artikel
|
| 33 |
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries
|
Saini, K.S.
|
|
|
23 |
4 |
p. 853-859
|
artikel
|
| 34 |
Salvage or savage chemotherapy for poor-risk or relapsed testis cancer—20 years later, not much has changed
|
Raghavan, D.
|
|
|
23 |
4 |
p. 813-814
|
artikel
|
| 35 |
Table of Contents
|
|
|
|
23 |
4 |
p. iv-vi
|
artikel
|
| 36 |
The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma
|
Erčulj, N.
|
|
|
23 |
4 |
p. 961-967
|
artikel
|
| 37 |
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy
|
Suzuki, C.
|
|
|
23 |
4 |
p. 948-954
|
artikel
|
| 38 |
The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma
|
Qin, C.
|
|
|
23 |
4 |
p. 981-989
|
artikel
|
| 39 |
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
|
Serrano, C.
|
|
|
23 |
4 |
p. 897-902
|
artikel
|
| 40 |
Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80
|
Janssen-Heijnen, M.L.G.
|
|
|
23 |
4 |
p. 954-960
|
artikel
|
| 41 |
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis
|
Fasol, U.
|
|
|
23 |
4 |
p. 1030-1036
|
artikel
|
Tijdschrift beschrijving